March 28 (Reuters) - S2Medical AB (publ) S2ME.ST :
* S2MEDICAL IMPLEMENTS A STRATEGIC CHANGE TO REACH
PROFITABILITY
FASTER
* TO IMPLEMENT A STRATEGIC CHANGE WHICH MEANS THAT ALL
AVAILABLE
RESOURCES WILL BE USED TO ACHIEVE INCREASED GROWTH.
* WILL THEREFORE PAUSE ALL ACTIVITIES RELATED TO RESEARCH
AND
DEVELOPMENT AND CLINICAL STUDIES.
* TECHNOLOGY FOR DEALING WITH MULTI-RESISTANT BACTERIA WILL
NOT BE
AFFECTED BY THIS REORGANIZATION
* REORGANIZATION WILL RESULT IN A REDUCED BURN RATE AND MAKE
AVAILABLE RESOURCES THAT CAN BE ALLOCATED TO EXPANDING SALES
* WILL FOCUS SOLELY ON INCREASING TURNOVER THROUGH SALE OF
EXISTING PRODUCTS.
* PARTS OF STREAMLINING INCLUDE RENTAL AGREEMENTS AND LIKE,
MEANING THAT EFFECTS WILL BE REALIZED GRADUALLY DURING CURRENT
YEAR
* CFO, HAS CHOSEN TO TERMINATE HER EMPLOYMENT.
* COO, MÅRTEN SKOG, WILL BE RESPONSIBLE FOR FINANCIAL
REPORTING
WITH SUPPORT FROM AN EXTERNAL CONSULTANT
Source text for Eikon: ID:nWkr4Vk6YW
Further company coverage: S2ME.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))